| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5701524 | Journal of Thoracic Oncology | 2017 | 30 Pages |
Abstract
In both trials, the rate of detection of T790M mutation in patients with advanced NSCLC was approximately 63% and was unaffected by immediately prior treatment with an EGFR TKI or ethnicity.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Suzanne DPhil, James M.B.B.S., MD, Pasi A. MD, PhD, Kenneth S. PhD, Karen BA, Rachel MSc, Susie BSc, Simon MSc, Sabina PhD, Mireille MD, Frances A. MD,